Ralph W. Kuncl has been appointed to a second, five-year term as Provost and Executive Vice President of the University of Rochester. He has also been named the University’s Chief Research Officer. His appointment was recommended by University President Joel Seligman and has been approved by the University Board of Trustees.
“Ralph has been particularly outstanding in balancing three fundamental areas of responsibility,” Seligman said. “First, that of Senior Leader at the University with involvement on virtually every significant senior leadership team at the University, including those that address budget and 19 University-wide committees including Conflicts of Interest. Second, Chief Academic Officer, where, among other things, Ralph has had the lead oar in reviewing 102 tenure or promotion decisions, decanal reviews, and administering several awards and benefits programs, as well as his role with respect to our deans, libraries, faculty diversity, multidisciplinary initiatives, and celebration of our faculty and students through events, including the much lauded Celebration of the Book. Third, de facto Chief Research Officer, where Ralph has orchestrated the quite successful initiation of the Health Sciences Center for Computation Innovation, the Sponsored University Research Group, chairs the Technology Transfer Policy Committee and recently worked with the IT Steering Group in helping move us toward selection of a new cloud-based Financial Reporting System.”
Neil Shull, associate in the biotechnology/chemical practice group at Sterne Kessler Goldstein Fox, will present a free talk, “Patenting Biomarkers and Diagnostic Methods,” at 9 a.m. Thursday, March 8, in the Class of ’62 Auditorium (G-9425 and 1-2495) at the Medical Center. The talk, which will examine strategies to improve successful outcomes at the patent office, is part of the FIRE Lecture Series. Breakfast refreshments will be provided. Register at 784-8856 or email David Englert.
The University’s Technology Development Fund is accepting pre-proposal applications for its fifth round of award funding. The fund promotes the transfer and translation of University research into commercial applications through monetary awards ranging from $40,000 to $100,000. New for 2012, the application has been streamlined and therapeutics/vaccines proposals will be evaluated using updated criteria, bettering the chances for an award in that area.
Foundation announces a comprehensive, two-day educational experience for founders of early-stage medical device, therapeutics, diagnostics and digital health companies
(KANSAS CITY, Mo.) Feb. 23, 2011 — Life science startups face more complex and daunting hurdles than new enterprises in non-regulated industries do. To help aspiring and early-stage life science entrepreneurs address these challenges, the Ewing Marion Kauffman Foundation will hold a Kauffman Life Science Ventures Summit June 22-23, 2012.
The Foundation announced a call for applications today for the inaugural Summit, scheduled at the Mission Bay Conference Center at the University of California-San Francisco.
To learn more…
Please note the next Conversations in Entrepreneurship Lecture has been rescheduled to Wednesday, March 21st and will be held in Weiskotten Hall, Room 103.
Rhett Weiss, Executive Director of the Entrepreneurship and Innovation Institute at Cornell’s Johnson School of Management, will present “Cultivating an Entrepreneurial Mindset”.
Wednesday, March 21, 2012
Reception 4:30 PM
Talk 5:00 PM
Room 103 Weiskotten Hall, SUNY Upstate, 766 Irving Ave, Syracuse NY 13210
RSVP to Kathy Pazaras, email@example.com